Skip to content

Improving Antibiotic Prescribing for Urinary Tract Infections in Frail Elderly

The Improving Rational Prescribing for Urinary Tract Infections in Frail Elderly (ImpresU) Project - Work Package 2 (WP2): a Cluster Randomised Multifaceted Antibiotic Stewardship Intervention Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03970356
Acronym
ImpresU-WP2
Enrollment
1146
Registered
2019-05-31
Start date
2019-09-01
Completion date
2021-07-21
Last updated
2022-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Tract Infections

Keywords

cluster randomized trial, antibiotic stewardship, frail elderly

Brief summary

The purpose of this study is to determine whether a tailored multifaceted antibiotic stewardship intervention reduces antibiotic use for urinary tract infections in residential care homes and nursing homes attended by general practitioners. This will be evaluated in a pragmatic cluster randomised controlled trial using a modified community-based participatory action research approach.

Detailed description

Rationale: Almost 60% of antibiotics in frail elderly is prescribed for alleged UTI. About half of the antibiotics for UTI in this population are prescribed for non-specific signs and symptoms; a substantial part of these prescriptions might not be necessary. Research question: Does a tailored multifaceted antibiotic stewardship intervention reduce antibiotic use for UTI in residential care homes and nursing homes attended by general practitioners (GPs)? Study design, setting and population: A pragmatic cluster randomised controlled trial using a modified community-based participatory action research approach. In the intervention group the latest UTI guidelines (which are standard care) are actively implemented at the level of the GP/caregivers. Residents ≥ 70 year with ADL dependency from 34 care homes + attending GP practices will participate in Norway, Sweden, Poland and the Netherlands. Methods: The study has two measurement periods; a baseline period (5 months) and a follow-up period (7 months). In between the antibiotic stewardship intervention will be tailored and implemented in intervention practices. GPs will prospectively register suspected UTIs on standardized registration forms and (study) nurses/assistants will follow-up patients at day 7 and day 21 for each UTI. Patients will be enrolled prior to the start of the study. * June-August 2019: patient are recruited, informed consent is obtained, baseline characteristics of patients are recorded * Sept 2019: study starts (from this moment onwards, the outcomes are being assessed). Data analysis: The primary analysis will be to assess the number of prescriptions of antibiotics for suspected UTI in the follow-up period, correcting for the baseline period and controlled for pre-specified confounders, using a generalized linear mixed model for Poisson distributions.

Interventions

The intervention is multifaceted, consisting of the implementation of an algorithm for restrictive use of antibiotics as proposed in recent guidelines (Verenso, Dutch guideline), tailored in close collaboration with local stakeholders to the specific implementation setting, by means of a modified participatory-action research (PAR) approach. To support the process of intervention-tailoring and -implementation, a toolbox comprising of materials, aids and actions is developed to be used at the discretion of the local stakeholders to support implementation of the algorithm.The algorithm is congruent with the Swedish and Norwegian guidelines, which also promote more restrictive use of antibiotics in case of non-specific symptoms, even though the algorithm is more detailed.

Sponsors

UMC Utrecht
CollaboratorOTHER
Medical University of Lodz
CollaboratorOTHER
University of Oslo
CollaboratorOTHER
Vastra Gotaland Region
CollaboratorOTHER_GOV
Göteborg University
CollaboratorOTHER
Cees Hertogh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

The investigators will perform a pragmatic cluster randomised controlled trial (cRCT). The targeted population consists of frail elderly residents of residential care homes and nursing homes attended by general practitioners. The clusters (care home + general practitioners) are assigned to intervention- or control group. In the intervention group, an antibiotic stewardship intervention is actively implemented at the level of the general practitioners and caregivers in the homes. The study has two measurement periods; a baseline period (5 months) and a follow-up period (7 months). In between there is an implementation period in which the intervention (i.e. active implementation) is started in the intervention homes \[no measurements are taken\].

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* physical and/or mental disabilities and ADL dependency requiring residential care or nursing home care * attended by general practitioners * not on continuous prophylactic antibiotic use

Exclusion criteria

* in hospice-care * very limited life expectancy (≤1 month) * no longer wish to participate * start continuous antibiotic (prophylaxis) * die or move away from the residential care home / nursing home If patients are excluded within 2 months after inclusion, they will be taken out of the study. In other words: patients need to be included for at least 2 months to contribute data to the study.

Design outcomes

Primary

MeasureTime frameDescription
UTI prescriptionsAssessed during the 7-month follow-up periodNumber of prescriptions of antibiotics for suspected urinary tract infections expressed per patient-year

Secondary

MeasureTime frameDescription
UTI suspicionsAssessed during the 7-month follow-up periodIncidence of suspected UTI expressed per patient-year
ComplicationsAssessed during the 7-month follow-up periodIncidence of complications: delirium, pyelonephritis, sepsis and renal failure within 21 days after each UTI suspicion
Hospital referralAssessed during the 7-month follow-up periodIncidence of referral to a hospital within 21 days after each UTI suspicion
Incorrect UTI prescriptionsAssessed during the 7-month follow-up periodNumber of incorrect prescriptions of antibiotics for suspected UTI expressed per patient-year
MortalityAssessed during the 7-month follow-up periodMortality
Mortality after UTI suspicionAssessed during the 7-month follow-up periodMortality within 21 days after each UTI suspicion
UTI prescriptions in office hoursAssessed during the 7-month follow-up periodNumber of prescriptions of antibiotics for suspected UTI in office hours expressed per patient-year
Hospital admissionAssessed during the 7-month follow-up periodIncidence of hospital admission within 21 days after each UTI suspicion

Countries

Netherlands, Norway, Poland, Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026